New data suggest more is better, but choices come with tradeoffs ...
Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...
SER-155 recipients achieved immunosuppressive-free clinical response of diarrhea (a primary symptom of irEC) at Day 15 in the ...
Once regarded as a disease affecting people over the age of 50, colorectal cancer is now rising at an alarming rate among ...
A quiet layer of biology is beginning to change how health is understood, and it sits on the surface of nearly every cell in ...
A research team at McMaster University has developed a targeted approach to treating inflammatory bowel disease (IBD) using ...
Brendan Camp, MD, FAAD, is a double board-certified dermatologist and assistant professor of dermatology at Weill Cornell Medical College. Five to 30 minutes of sun exposure on most days without ...